Narayana Hrudayalaya Gears Up for Scheme of Arrangement Approval
Narayana Hrudayalaya recorded revenue of ₹1366.68 crore and a profit of ₹192.94 crore in Q3 FY25.
Shareholders and creditors face key meetings on April 2, 2026, to vote on a Scheme of Arrangement involving NH Integrated Care Private Limited.
Reader Takeaway: Demerger aims for operational focus; shareholder approval remains a key hurdle.
What just happened (today’s filing)
Narayana Hrudayalaya Limited (NHL) has announced that its Board of Directors approved a Scheme of Arrangement on December 12, 2025. This scheme is designed for the demerger of the 'Clinical Services undertaking' of its wholly-owned subsidiary, NH Integrated Care Private Limited (NHIC), back into NHL.
The company has called for separate meetings of its equity shareholders, secured creditors, and unsecured creditors to be held on April 2, 2026. These meetings will be conducted via video conferencing (VC) or other audio-visual means (OAVM) to consider and approve the proposed scheme.
Key dates include a shareholder e-voting cut-off of March 27, 2026, and a creditor e-voting cut-off of October 31, 2025. The remote e-voting period for all stakeholders will be from March 30, 2026, to April 1, 2026.
Why this matters
This restructuring aims to create more focused business entities. By transferring the clinical services back to the parent, NHIC can concentrate exclusively on its 'Narayana Aarogyam' preventive healthcare platform, enabling sharper focus and potentially unlocking distinct business models and enhanced valuations.
The move is expected to optimize resource efficiency, consolidate administrative functions, and facilitate a more streamlined approach to patient care and specialized services across the group.
The backstory (grounded)
NH Integrated Care Private Limited (NHIC) was incorporated on January 10, 2023, as a wholly-owned subsidiary of Narayana Hrudayalaya Limited. Its initial objective was to provide health and wellness management services.
The demerged undertaking involves 10 clinics in Bengaluru, which contributed a turnover of ₹39.94 crore in FY25. This represents a relatively small fraction, about 1.11%, of Narayana Hrudayalaya's total standalone turnover for the same period.
What changes now
- Shareholders will vote on a corporate restructuring that aims to simplify the group's operational structure.
- The demerger is intended to enhance the focus of NHIC on its preventive healthcare vertical.
- Narayana Hrudayalaya Limited will re-integrate the clinical services, potentially streamlining management and operations.
- No immediate change in the shareholding pattern is expected, as NHIC is a wholly-owned subsidiary.
Risks to watch
- The primary risk is the outcome of the shareholder and creditor meetings; approval is contingent on their consent.
- Regulatory approvals from authorities such as the National Company Law Tribunal (NCLT) will be critical for the scheme's implementation.
- Successful integration of the demerged clinical services back into NHL and continued operational efficiency.
Peer comparison
Major hospital chains like Apollo Hospitals, Fortis Healthcare, and Max Healthcare typically operate highly integrated models, often expanding through acquisitions or greenfield projects rather than demerging specific operational units back to the parent.
While these peers focus on broad service offerings, Narayana Hrudayalaya's move is specific to separating a preventive healthcare platform from clinical services for enhanced focus.
Context metrics (time-bound)
- Narayana Hrudayalaya's Q3 FY25 standalone revenue stood at ₹1366.68 crore, with a net profit of ₹192.94 crore.
- The demerged clinical services undertaking contributed ₹39.94 crore to NHL's standalone turnover in FY25.
What to track next
- Outcomes of the shareholder, secured creditor, and unsecured creditor meetings on April 2, 2026.
- Subsequent regulatory filings and approvals required for the Scheme of Arrangement.
- Management's commentary on the expected benefits and integration timeline post-approval.
